 Friedreichs ataxia is a rare genetic disorder characterized by severe neurological disability and cardiomyopathy. Friedreichs ataxia is the consequence of frataxin deficiency. Although several drugs have been proposed, there is no available treatment. It was recently demonstrated that erythropoietin can increase the intracellular levels of frataxin in an in-vitro model. 